bibliographic resource 334684 [br/334684]
https://w3id.org/oc/corpus/br/334684

is a
title
  • Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study
publication date
  • 2012-01-01
contributor
format
identifier
part of